Nanoparticle‐Based Formulations of Glycopeptide Antibiotics: A Means for Overcoming Vancomycin Resistance in Bacterial Pathogens?
The occurrence and spreading of multidrug resistance in bacterial pathogens represent one of the greatest challenges of the 21st century. With fewer and fewer new antibiotics in development, novel and unconventional concepts in drug development and formulation need to be explored to overcome the glo...
Main Authors: | Bhanu Kiran Pothineni, Adrian Keller |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2023-04-01
|
Series: | Advanced NanoBiomed Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/anbr.202200134 |
Similar Items
-
Antimicrobial Activity of Nanoconjugated Glycopeptide Antibiotics and Their Effect on Staphylococcus aureus Biofilm
by: Francesca Berini, et al.
Published: (2021-12-01) -
The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
by: Ilona Bereczki, et al.
Published: (2022-01-01) -
Evaluation of errors during susceptibility reporting of glycopeptide antibiotics for enterococcal isolates on sole basis of widely used disk diffusion test
by: Vikas Saini, et al.
Published: (2022-12-01) -
Hybrid Antibiotics Based on Azithromycin and Glycopeptides: Synthesis and Antibacterial Activity
by: S. S. Printsevskaya, et al.
Published: (2020-05-01) -
A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
by: Aurora Montali, et al.
Published: (2020-06-01)